NPA chairman Olivier Picard said ‘many more people are interested in getting weight loss jabs than would actually be suitable ...

FAT jab supplies could run out — with one in five people ­trying to buy them last year. Pharmacists warn that ballooning demand “goes far beyond what is clinically deliverable”. Millions of Brits ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

The researchers observed “significant” weight regain at eight, 12, and 20 weeks after discontinuation. They deduced that most patients gain back the weight they initially lost for an average of 20 ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...